4 terminated. 4 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow donafenib: new trials by email Literature Review of donafenib trials Research Report on donafenib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. HAIC, TACE, FOLFOX - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Terminated | Peking University | 18 | 2021-12-24 | 2025-12-18 |
| Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma Donafenib - Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | Terminated | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 20 | 2017-02-08 | 2023-05-08 |
| Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer donafenib tosilate tablets - Gastric Cancer | Phase 1 / Phase 2 | Terminated | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 13 | 2016-05-16 | 2023-05-08 |
| A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer donafenib tosilate tablets - Oesophageal Cancer | Phase 1 / Phase 2 | Terminated | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 19 | 2015-07-21 | 2023-06-15 |
Carcinoma, Hepatocellular (1) · Esophageal Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Stomach Neoplasms (1)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd (3) · Peking University (1)
China (4)
Bao Rui, Doctor (1) · Jianming Xu, Doctor (1) · Xiaodong Wang, MD (1) · Yuan Kai Shi, Doctor (1)